GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (XSWX:YPSN) » Definitions » Enterprise Value

Ypsomed Holding AG (XSWX:YPSN) Enterprise Value : CHF4,683.6 Mil (As of May. 04, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Ypsomed Holding AG's Enterprise Value is CHF4,683.6 Mil. Ypsomed Holding AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was CHF81.6 Mil. Therefore, Ypsomed Holding AG's EV-to-EBIT ratio for today is 57.40.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Ypsomed Holding AG's Enterprise Value is CHF4,683.6 Mil. Ypsomed Holding AG's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was CHF158.7 Mil. Therefore, Ypsomed Holding AG's EV-to-EBITDA ratio for today is 29.52.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Ypsomed Holding AG's Enterprise Value is CHF4,683.6 Mil. Ypsomed Holding AG's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was CHF508.6 Mil. Therefore, Ypsomed Holding AG's EV-to-Revenue ratio for today is 9.21.


Ypsomed Holding AG Enterprise Value Historical Data

The historical data trend for Ypsomed Holding AG's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Enterprise Value Chart

Ypsomed Holding AG Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,608.58 1,746.04 2,197.76 2,311.88 2,757.79

Ypsomed Holding AG Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,965.42 2,311.88 2,005.74 2,757.79 3,642.03

Competitive Comparison of Ypsomed Holding AG's Enterprise Value

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Enterprise Value falls into.



Ypsomed Holding AG Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Ypsomed Holding AG's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as

Ypsomed Holding AG's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG  (XSWX:YPSN) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Ypsomed Holding AG's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4683.630/81.603
=57.40

Ypsomed Holding AG's current Enterprise Value is CHF4,683.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was CHF81.6 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Ypsomed Holding AG's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=4683.630/158.669
=29.52

Ypsomed Holding AG's current Enterprise Value is CHF4,683.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was CHF158.7 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Ypsomed Holding AG's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4683.630/508.606
=9.21

Ypsomed Holding AG's current Enterprise Value is CHF4,683.6 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Ypsomed Holding AG's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was CHF508.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG Enterprise Value Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (XSWX:YPSN) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (XSWX:YPSN) Headlines

No Headlines